Literature DB >> 436359

Dose-dependent prednisolone kinetics.

A Tanner, F Bochner, J Caffin, J Halliday, L Powell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 436359     DOI： 10.1002/cpt1979255part1571

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  24 in total

1.  Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.

Authors:  J A Wald; R M Law; E A Ludwig; R R Sloan; E Middleton; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

Review 2.  Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.

Authors:  E G Quetglas; A Armuzzi; S Wigge; G Fiorino; L Barnscheid; M Froelich; Silvio Danese
Journal:  Eur J Clin Pharmacol       Date:  2015-05-27       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Dose-dependent pharmacokinetics of dexamethasone.

Authors:  D Loew; O Schuster; E H Graul
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Effect of intra-articular glucocorticoids on the disposition of sulphadimidine in chronic osteoarthritis patients.

Authors:  P T Reeves; P Hanrahan; J Edelman; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 6.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

7.  Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.

Authors:  W A McAllister; D M Mitchell; J V Collins
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

8.  Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin.

Authors:  K H Lee; J G Shin; W S Chong; S Kim; J S Lee; I J Jang; S G Shin
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Absorption of prednisolone in patients with Crohn's disease.

Authors:  J A Shaffer; S E Williams; L A Turnberg; J B Houston; M Rowland
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

10.  Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Authors:  P J Meffin; P M Brooks; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.